Redmond Asset Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.19M Buy
20,975
+564
+3% +$94K 0.8% 32
2026
Q1
$4.28M Sell
20,411
-44
-0.2% -$11.1K 1.17% 18
2025
Q4
$5.81M Sell
20,455
-296
-1% -$92.5K 1.48% 14
2025
Q3
$6.41M Sell
20,751
-26
-0.1% -$8.15K 1.57% 12
2025
Q2
$6.53M Sell
20,777
-689
-3% -$199K 1.56% 14
2025
Q1
$5.64M Sell
21,466
-294
-1% -$79.6K 1.45% 15
2024
Q4
$5.68M Buy
21,760
+34
+0.2% +$8.56K 1.42% 15
2024
Q3
$5.06M Sell
21,726
-43
-0.2% -$8.83K 1.59% 16
2024
Q2
$4.39M Buy
21,769
+9,354
+75% +$1.69M 1.45% 18
2024
Q1
$2.13M Buy
12,415
+209
+2% +$39K 0.68% 54
2023
Q4
$2.65M Buy
+12,206
New +$2.09M 0.85% 33

Other funds holding PODD

Redmond Asset Management's PODD Position: Q2 2026 in Review

Redmond Asset Management increased its Insulet (PODD) stake by 2.8% in Q2 2026, buying an estimated $94K and bringing the position to 20,975 shares worth $3.19M. The position accounts for 0.8% of the portfolio, ranked #32.

Redmond Asset Management first reported a position in PODD in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.53M in Q2 2025. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Redmond Asset Management held 20,975 shares of Insulet worth $3.19M as of Q2 2026.
  • Redmond Asset Management bought 564 Insulet shares in Q2 2026, an estimated $94K.
  • Insulet made up 0.8% of Redmond Asset Management's portfolio in Q2 2026, its #32 holding.
  • Redmond Asset Management first reported a position in Insulet in Q4 2023 and has held it in 11 quarters since.
  • Redmond Asset Management's Insulet position peaked at $6.53M in Q2 2025.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Redmond Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.